Small-cell lung cancer (SCLC) is one of the most lethal cancers, with patients diagnosed with extensive-stage small-cell lung cancer (ES-SCLC) experiencing a median survival of just 12 months after ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech', 6990.HK) today announced that results from its ...

What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

Air pollution in India linked to rising lung cancer cases, emphasizing the urgent need for research and action.

Drugs that boost the body's immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

Brain metastases are common in people with non-small cell lung cancer. Here’s how they’re treated and diagnosed. Lung cancer is one of the cancers most likely to spread to the brain.

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell ... t spread outside your lung, to 8% if it has spread to other areas of your body like your brain, bones ...

It’s cancer that starts ... Adenocarcinoma can spread to the lymph nodes, bones, or other organs such as the liver. Squamous cell carcinoma usually starts in the lung’s largest branches ...

Lung cancer in general, and non-small cell lung cancer (NSCLC ... The typical sites of metastasis for NSCLC include the brain, bones, liver, adrenal glands and the contralateral lung; metastasis ...

Prior to this study, AM-101's effect in non-small cell lung cancer was unknown. AM-101 is a particularly useful drug in the context of brain metastases in NSCLC, Bhattacharya said, as ...